Therapeutic Asset Ratings
147 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Mesenchymal Stem Cells Derived Exosomes
Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Mutant Kras G12V-Specific Tcr Transduced Autologous T Cells
Pancreatic Ductal Adenocarcinoma
Changhai Hospital
P1/2
CC
(41)
Nesuparib
Pancreatic Ductal Adenocarcinoma
Onconic Therapeutics Inc.
P1/2
CC
(41)
ngm707
Pancreatic Ductal Adenocarcinoma
NGM Biopharmaceuticals, Inc
P1/2
CC
(41)
Nlm-001
Pancreatic Ductal Adenocarcinoma
Nelum Corp
P1/2
CC
(41)
Tegavivint
Pancreatic Ductal Adenocarcinoma
Children's Oncology Group
P1/2
CC
(41)
Zalifrelimab
Pancreatic Ductal Adenocarcinoma
Nelum Corp
P1/2
CC
(41)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101)
Pancreatic Ductal Adenocarcinoma
Fudan University
P1
CC
(40)
gsk1120212
Pancreatic Ductal Adenocarcinoma
Peter Hosein, MD
P1
CC
(40)
ro7496353
Pancreatic Ductal Adenocarcinoma
Genentech, Inc.
P1
CC
(40)
Ruxolitinib
Pancreatic Ductal Adenocarcinoma
Peter Hosein, MD
P1
CC
(40)
[111in]-fpi-2107
Pancreatic Ductal Adenocarcinoma
AstraZeneca
P1
C
(37)
177lu-dfc413
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
C
(37)
177lu-ff58
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
C
(37)
[177lu]lu-nns309
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
C
(37)
[225ac]-fpi-2068
Pancreatic Ductal Adenocarcinoma
AstraZeneca
P1
C
(37)
64Cu-Tz-SarAr
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1
C
(37)
[68Ga]Ga-NNS309
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
C
(37)
Abbv-400
Pancreatic Ductal Adenocarcinoma
AbbVie
P1
C
(37)
ag-120
Pancreatic Ductal Adenocarcinoma
Case Comprehensive Cancer Center
P1
C
(37)
Amt-151
Pancreatic Ductal Adenocarcinoma
Multitude Therapeutics Inc.
P1
C
(37)
AQUOCOBALAMIN
Pancreatic Ductal Adenocarcinoma
General Oncology, Inc.
P1
C
(37)
asp2138
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Global Development, Inc.
P1
C
(37)
asp5834
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Inc
P1
C
(37)
atp150
Pancreatic Ductal Adenocarcinoma
Boehringer Ingelheim
P1
C
(37)
Showing 76 to 100 of 147 assets
Previous
Page 4 of 6
Next
